Viewing Study NCT02686593


Ignite Creation Date: 2025-12-25 @ 1:23 AM
Ignite Modification Date: 2025-12-27 @ 11:21 PM
Study NCT ID: NCT02686593
Status: COMPLETED
Last Update Posted: 2022-10-06
First Post: 2016-02-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Clofarabine, Cytarabine and Mitoxantrone (CLAM) for Relapsed or Refractory AML
Sponsor: The University of Hong Kong
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module